Global Organ-On-Chip (OOC) Market Insights and Forecast to 2028

An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and air flow in organs, such as lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional 2D and 3D culture systems. It offers a wide range of applications, such as diseases modeling, patient stratification, and phenotypic screening.
Market Analysis and Insights: Global Organ-On-Chip (OOC) Market
Due to the COVID-19 pandemic, the global Organ-On-Chip (OOC) market size is estimated to be worth US$ 80 million in 2022 and is forecast to a readjusted size of US$ 581.2 million by 2028 with a CAGR of 39.1% during the review period. Fully considering the economic change by this health crisis, Brain-on-a-chip accounting for % of the Organ-On-Chip (OOC) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical & Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.
China Organ-On-Chip (OOC) market size is valued at US$ million in 2021, while the US and Europe Organ-On-Chip (OOC) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Organ-On-Chip (OOC) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Organ-On-Chip (OOC) include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis and Micronit Microtechnologies B.V., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Organ-On-Chip (OOC) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Organ-On-Chip (OOC) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Organ-On-Chip (OOC) Scope and Segment
Organ-On-Chip (OOC) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Organ-On-Chip (OOC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Other
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Other
By Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Production by Region
North America
Europe
China
Japan
South Korea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions